IL23A and cancer: Lactate secreted by tumor cells increased the transcription of IL-23p19 and IL-23 in monocytes/macrophages and tumor-infiltrating immune cells, implying that lactate is not only a terminal metabolite but also a proinflammatory mediator, and thus, targeting the lactate-induced proinflammatory response may be a therapeutic strategy for cancer [55].